{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ACE2", "COVID-19", "SARS-CoV-2.", "medicinal plants", "renin-angiotensin-system"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34012391", "DateRevised": {"Year": "2024", "Month": "04", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "05", "Day": "03"}], "Language": ["eng"], "ELocationID": ["629935", "10.3389/fphar.2021.629935"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies.", "Pagination": {"StartPage": "629935", "MedlinePgn": "629935"}, "Abstract": {"AbstractText": ["The 2019 coronavirus disease (COVID-19) is a potentially fatal multisystemic infection caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Currently, viable therapeutic options that are cost effective, safe and readily available are desired, but lacking. Nevertheless, the pandemic is noticeably of lesser burden in African and Asian regions, where the use of traditional herbs predominates, with such relationship warranting a closer look at ethnomedicine. From a molecular viewpoint, the interaction of SARS-CoV-2 with angiotensin converting enzyme 2 (ACE2) is the crucial first phase of COVID-19 pathogenesis. Here, we review plants with medicinal properties which may be implicated in mitigation of viral invasion either via direct or indirect modulation of ACE2 activity to ameliorate COVID-19. Selected ethnomedicinal plants containing bioactive compounds which may prevent and mitigate the fusion and entry of the SARS-CoV-2 by modulating ACE2-associated up and downstream events are highlighted. Through further experimentation, these plants could be supported for ethnobotanical use and the phytomedicinal ligands could be potentially developed into single or combined preventive therapeutics for COVID-19. This will benefit researchers actively looking for solutions from plant bioresources and help lessen the burden of COVID-19 across the globe."], "CopyrightInformation": "Copyright \u00a9 2021 Abubakar, Usman, El-Saber Batiha, Cruz-Martins, Malami, Ibrahim, Abubakar, Bello, Muhammad, Gan, Dabai, Alblihed, Ghosh, Badr, Thangadurai and Imam."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Faculty of Basic Medical Sciences, College of Health Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria."}, {"Identifier": [], "Affiliation": "Centre for Advanced Medical Research and Training, Usmanu Danfodiyo University, Sokoto, Nigeria."}], "LastName": "Abubakar", "ForeName": "Murtala Bello", "Initials": "MB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Faculty of Basic Medical Sciences, College of Health Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria."}, {"Identifier": [], "Affiliation": "Centre for Advanced Medical Research and Training, Usmanu Danfodiyo University, Sokoto, Nigeria."}], "LastName": "Usman", "ForeName": "Dawoud", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt."}], "LastName": "El-Saber Batiha", "ForeName": "Gaber", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, University of Porto, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Laboratory of Neuropsychophysiology, Faculty of Psychology and Education Sciences, University of Porto, Porto, Portugal."}], "LastName": "Cruz-Martins", "ForeName": "Nat\u00e1lia", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Advanced Medical Research and Training, Usmanu Danfodiyo University, Sokoto, Nigeria."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy and Ethnopharmacy, Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria."}], "LastName": "Malami", "ForeName": "Ibrahim", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Faculty of Basic Medical Sciences, College of Health Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria."}, {"Identifier": [], "Affiliation": "Centre for Advanced Medical Research and Training, Usmanu Danfodiyo University, Sokoto, Nigeria."}], "LastName": "Ibrahim", "ForeName": "Kasimu Ghandi", "Initials": "KG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Advanced Medical Research and Training, Usmanu Danfodiyo University, Sokoto, Nigeria."}, {"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria."}], "LastName": "Abubakar", "ForeName": "Bilyaminu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Advanced Medical Research and Training, Usmanu Danfodiyo University, Sokoto, Nigeria."}, {"Identifier": [], "Affiliation": "Department of Veterinary Microbiology, Faculty of Veterinary Medicine, Usmanu Danfodiyo University, Sokoto, Nigeria."}], "LastName": "Bello", "ForeName": "Muhammad Bashir", "Initials": "MB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Kaduna Sate, Nigeria."}], "LastName": "Muhammad", "ForeName": "Aliyu", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia."}], "LastName": "Gan", "ForeName": "Siew Hua", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Advanced Medical Research and Training, Usmanu Danfodiyo University, Sokoto, Nigeria."}, {"Identifier": [], "Affiliation": "Department of Microbiology, Usmanu Danfodiyo University, Sokoto, Nigeria."}], "LastName": "Dabai", "ForeName": "Aliyu Ibrahim", "Initials": "AI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, College of Medicine, Taif University, Taif, Saudi Arabia."}], "LastName": "Alblihed", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology Division, Department of Botany, Gauhati University, Guwahati, India."}], "LastName": "Ghosh", "ForeName": "Arabinda", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany and Microbiology, Faculty of Science, Alexandria University, Alexandria, Egypt."}], "LastName": "Badr", "ForeName": "Reem H", "Initials": "RH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, Karnatak University, Dharwad, India."}], "LastName": "Thangadurai", "ForeName": "Devarajan", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Advanced Medical Research and Training, Usmanu Danfodiyo University, Sokoto, Nigeria."}, {"Identifier": [], "Affiliation": "Department of Medical Biochemistry, Faculty of Basic Medical Sciences, College of Health Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria."}], "LastName": "Imam", "ForeName": "Mustapha Umar", "Initials": "MU"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abdelli I., Hassani F., Bekkel Brikci S., Ghalem S. (2020). In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria. J. Biomol. Struct. Dyn., 1\u201314. 10.1080/07391102.2020.1763199", "ArticleIdList": ["10.1080/07391102.2020.1763199", "PMC7232889", "32362217"]}, {"Citation": "\nAfrica C. D. C. (2020). Statement on herbal remedies and medicines for prevention and treatment of COVID-19. Africa centres for disease control and prevention: african union\nAvailable from: https://africacdc.org/download/statement-on-herbal-remedies-and-medicines-for-prevention-and-treatment-of-covid-19-2/ (Accessed October 11, 2020). "}, {"Citation": "Alexpandi R., De Mesquita J. F., Pandian S. K., Ravi A. V. (2020). Quinolines-based SARS-CoV-2 3CLpro and RdRp inhibitors and spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: an in silico analysis. Front. Microbiol. 11. 10.3389/fmicb.2020.01796", "ArticleIdList": ["10.3389/fmicb.2020.01796", "PMC7390959", "32793181"]}, {"Citation": "Balkrishna A., Pokhrel S., Singh J., Varshney A. (2020). Withanone from Withania somnifera may inhibit novel Coronavirus (COVID-19) entry by disrupting interactions between viral S-protein receptor binding domain and host ACE2 receptor. Res. Square .10.21203/rs.3.rs-17806/v1", "ArticleIdList": ["10.21203/rs.3.rs-17806/v1"]}, {"Citation": "Basu A., Sarkar A., Maulik U. (2020). Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2. Sci. Rep. 10 (1), 17699. 10.1038/s41598-020-74715-4", "ArticleIdList": ["10.1038/s41598-020-74715-4", "PMC7573581", "33077836"]}, {"Citation": "Bejjani S., Wu J. (2013). Transport of IRW, an ovotransferrin-derived antihypertensive peptide, in human intestinal epithelial caco-2 cells. J. Agric. Food Chem. 61 (7), 1487\u20131492. 10.1021/jf302904t", "ArticleIdList": ["10.1021/jf302904t", "23298184"]}, {"Citation": "Bestle D., Heindl M. R., Limburg H., Van Lam van T., Pilgram O., Moulton H., et al. (2020). TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci. alliance 3 (9). 10.26508/lsa.202000786", "ArticleIdList": ["10.26508/lsa.202000786", "PMC7383062", "32703818"]}, {"Citation": "Bhalla V., Blish C. A., South A. M. (2020). A historical perspective on ACE2 in the COVID-19 era. J. Hum. Hypertens. 10.1038/s41371-020-00459-3", "ArticleIdList": ["10.1038/s41371-020-00459-3", "PMC7735396", "33318644"]}, {"Citation": "Borkotoky S., Banerjee M. (2020). A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem). J. Biomol. Struct. Dyn. 1-17 10.1080/07391102.2020.1774419", "ArticleIdList": ["10.1080/07391102.2020.1774419", "PMC7311162", "32462988"]}, {"Citation": "Bourgonje A. R., Abdulle A. E., Timens W., Hillebrands J. L., Navis G. J., Gordijn S. J., et al. (2020). Angiotensin\u2010converting enzyme 2 ( ACE2 ), SARS\u2010CoV \u20102 and the pathophysiology of coronavirus disease 2019 ( COVID \u201019). J. Pathol. 251 (3), 228\u2013248. 10.1002/path.5471", "ArticleIdList": ["10.1002/path.5471", "PMC7276767", "32418199"]}, {"Citation": "Campos M., Guerrero L., Betancur D., Hernandez-Escalante V. (2011). Bioavailability of bioactive peptides. Food Rev. Int. 27, 213\u2013226. 10.1080/87559129.2011.563395", "ArticleIdList": ["10.1080/87559129.2011.563395"]}, {"Citation": "Chakrabarti S., Guha S., Majumder K. (2018). Food-derived bioactive peptides in human health: challenges and opportunities. Nutrients 10 (11), 1738. 10.3390/nu10111738", "ArticleIdList": ["10.3390/nu10111738", "PMC6265732", "30424533"]}, {"Citation": "Chen H., Du Q. (2020). Potential natural compounds for preventing SARS-CoV-2 (2019-nCoV) infection. 10.20944/preprints202001.0358.v3", "ArticleIdList": ["10.20944/preprints202001.0358.v3"]}, {"Citation": "Chen L., Li X., Chen M., Feng Y., Xiong C. (2020a). The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc. Res. 116 (6), 1097\u20131100. 10.1093/cvr/cvaa078", "ArticleIdList": ["10.1093/cvr/cvaa078", "PMC7184507", "32227090"]}, {"Citation": "Chen S. L., Yu H., Luo H. M., Wu Q., Li C. F., Steinmetz A. (2016). Conservation and sustainable use of medicinal plants: problems, progress, and prospects. Chin. Med. 11, 37. 10.1186/s13020-016-0108-7", "ArticleIdList": ["10.1186/s13020-016-0108-7", "PMC4967523", "27478496"]}, {"Citation": "Chen Y., Guo Y., Pan Y., Zhao Z. J. (2020b). Structure analysis of the receptor binding of 2019-nCoV. Biochem. Biophysical Res. Commun. 525 (1), 135\u2013140. 10.1016/j.bbrc.2020.02.071", "ArticleIdList": ["10.1016/j.bbrc.2020.02.071", "PMC7092824", "32081428"]}, {"Citation": "Chen Y., Liu Q., Guo D. (2020c). Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 92 (4), 418\u2013423. 10.1002/jmv.25681", "ArticleIdList": ["10.1002/jmv.25681", "PMC7167049", "31967327"]}, {"Citation": "Cheng L., Zheng W., Li M., Huang J., Bao S., Xu Q., et al. (2020). Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2. Preprints:", "ArticleIdList": ["PMC8844329", "35157175"]}, {"Citation": "Chikhale R. V., Gurav S. S., Patil R. B., Sinha S. K., Prasad S. K., Shakya A., et al. (2020a). Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach. J. Biomol. Struct. Dyn., 1\u201312 .10.1080/07391102.2020.1778539", "ArticleIdList": ["10.1080/07391102.2020.1778539", "PMC7332873", "32568012"]}, {"Citation": "Chikhale R. V., Sinha S. K., Patil R. B., Prasad S. K., Shakya A., Gurav N., et al. (2020b). In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19. J. Biomol. Struct. Dyn., 1\u201315 .10.1080/07391102.2020.1784289", "ArticleIdList": ["10.1080/07391102.2020.1784289", "32579064"]}, {"Citation": "Daak A. A., Lopez-Toledano M. A., Heeney M. M. (2020). Biochemical and therapeutic effects of omega-3 fatty acids in sickle cell disease. Complement. Therapies Med. 52. 102482. 10.1016/j.ctim.2020.102482", "ArticleIdList": ["10.1016/j.ctim.2020.102482", "32951732"]}, {"Citation": "de Kloet A. D., Krause E. G., Woods S. C. (2010). The renin angiotensin system and the metabolic syndrome. Physiol. Behav. 100 (5), 525\u2013534. 10.1016/j.physbeh.2010.03.018", "ArticleIdList": ["10.1016/j.physbeh.2010.03.018", "PMC2886177", "20381510"]}, {"Citation": "de Wit E., van Doremalen N., Falzarano D., Munster V. J. (2016). SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 14 (8), 523\u2013534. 10.1038/nrmicro.2016.81", "ArticleIdList": ["10.1038/nrmicro.2016.81", "PMC7097822", "27344959"]}, {"Citation": "Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., et al. (2000). A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87 (5), e1\u2013e9. 10.1161/01.res.87.5.e1", "ArticleIdList": ["10.1161/01.res.87.5.e1", "10969042"]}, {"Citation": "Enmozhi S. K., Raja K., Sebastine I., Joseph J. (2020). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. J. Biomol. Struct. Dyn. 1-7 10.1080/07391102.2020.1760136", "ArticleIdList": ["10.1080/07391102.2020.1760136", "PMC7212536", "32329419"]}, {"Citation": "Esparza T. J., Martin N. P., Anderson G. P., Goldman E. R., Brody D. L. (2020). High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme. Sci. Rep. 10 (1), 22370. 10.1038/s41598-020-79036-0", "ArticleIdList": ["10.1038/s41598-020-79036-0", "PMC7755911", "33353972"]}, {"Citation": "\nEuropean Centre for Disease Prevention and Control (2020). COVID-19 situation update worldwide, as of 26 September 2020\nAvailable from: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases (Accessed September 26, 2020). "}, {"Citation": "Fan C., Li K., Ding Y., Lu W. L., Wang J. (2020). ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection. medRxiv 10.1101/2020.02.12.20022418", "ArticleIdList": ["10.1101/2020.02.12.20022418", "PMC7838217", "33521006"]}, {"Citation": "Fougeroux C., Goks\u00f8yr L., Idorn M., Soroka V., Myeni S. K., Dagil R., et al. (2021). Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity. Nat. Commun. 12 (1), 324. 10.1038/s41467-020-20251-8", "ArticleIdList": ["10.1038/s41467-020-20251-8", "PMC7804149", "33436573"]}, {"Citation": "Furuhashi M., Moniwa N., Takizawa H., Ura N., Shimamoto K. (2020). Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19. Hypertens. Res. 43 (8), 837\u2013840. 10.1038/s41440-020-0478-1", "ArticleIdList": ["10.1038/s41440-020-0478-1", "PMC7237878", "32433641"]}, {"Citation": "Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.-C., Turner A. J., et al. (2020). Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system. Circ. Res. 126 (10), 1456\u20131474. 10.1161/circresaha.120.317015", "ArticleIdList": ["10.1161/circresaha.120.317015", "PMC7188049", "32264791"]}, {"Citation": "Glasgow A., Glasgow J., Limonta D., Solomon P., Lui I., Zhang Y., et al. (2020). Engineered ACE2 receptor traps potently neutralize SARS-CoV-2. Proc. Natl. Acad. Sci. USA 117 (45), 28046. 10.1073/pnas.2016093117", "ArticleIdList": ["10.1073/pnas.2016093117", "PMC7668070", "33093202"]}, {"Citation": "Guan W.-j., Ni Z.-y., Hu Y., Liang W.-h., Ou C.-q., He J.-x., et al. (2020). Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382 (18), 1708\u20131720. 10.1056/nejmoa2002032", "ArticleIdList": ["10.1056/nejmoa2002032", "PMC7092819", "32109013"]}, {"Citation": "G\u00fcler H. I., Tatar G., Yildiz O., Belduz A. O., Kolayli S. (2020). Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by Molecular Docking Study. ScienceOpen Preprints. 10.35206/jan.762734", "ArticleIdList": ["10.35206/jan.762734", "PMC8098016", "33950349"]}, {"Citation": "Gupta R., Misra A. (2020). Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc). Diabetes Metab. Syndr. Clin. Res. Rev. 14 (3), 251\u2013254. 10.1016/j.dsx.2020.03.012", "ArticleIdList": ["10.1016/j.dsx.2020.03.012", "PMC7102586", "32247213"]}, {"Citation": "\nGupte M. (2011). Role of angiotensin converting enzyme 2 (ACE2) in obesity -associated hypertension. Lexington, Kentucky: University of Kentucky Doctoral Dissertations; \nAvailable from:\u2009https://uknowledge.uky.edu/gradschool_diss/37 (Accessed October 28, 2020)."}, {"Citation": "Gutekunst W. R., Gianatassio R., Baran P. S. (2012). Sequential C sp 3\u2010H arylation and olefination: total synthesis of the proposed structure of pipercyclobutanamide A. Angew. Chem. Int. Ed. 51 (30), 7507\u20137510. 10.1002/anie.201203897", "ArticleIdList": ["10.1002/anie.201203897", "PMC3495593", "22715157"]}, {"Citation": "Gutierrez-Villagomez J. M., Campos-Garc\u00eda T., Molina-Torres J., L\u00f3pez M. G., V\u00e1zquez-Mart\u00ednez J. (2020). Alkamides and piperamides as potential antivirals against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). J. Phys. Chem. Lett. 11 (19), 8008\u20138016. 10.1021/acs.jpclett.0c01685", "ArticleIdList": ["10.1021/acs.jpclett.0c01685", "32840378"]}, {"Citation": "Haggag Y. A., El-Ashmawy N. E., Okasha K. M. (2020). Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection?. Med. Hypotheses 144, 109957. 10.1016/j.mehy.2020.109957", "ArticleIdList": ["10.1016/j.mehy.2020.109957", "PMC7274964", "32531538"]}, {"Citation": "Hamming I., Timens W., Bulthuis M., Lely A., Navis G., van Goor H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203 (2), 631\u2013637. 10.1002/path.1570", "ArticleIdList": ["10.1002/path.1570", "PMC7167720", "15141377"]}, {"Citation": "Hao Y., Liu Y. (2016). Osthole alleviates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2/angiotensin-(1-7) Axis and decreasing inflammation responses in rats. Biol. Pharm. Bull. 39 (4), 457\u2013465. 10.1248/bpb.b15-00358", "ArticleIdList": ["10.1248/bpb.b15-00358", "26822530"]}, {"Citation": "Haschke M., Schuster M., Poglitsch M., Loibner H., Salzberg M., Bruggisser M., et al. (2013). Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects. Clin. Pharmacokinet. 52 (9), 783\u2013792. 10.1007/s40262-013-0072-7", "ArticleIdList": ["10.1007/s40262-013-0072-7", "23681967"]}, {"Citation": "He R., Yang Y.-J., Wang Z., Xing C.-R., Yuan J., Wang L.-F., et al. (2019). Rapeseed protein-derived peptides, LY, RALP, and GHS, modulates key enzymes and intermediate products of renin-angiotensin system pathway in spontaneously hypertensive rat. NPJ Sci. Food 3, 1. 10.1038/s41538-018-0033-5", "ArticleIdList": ["10.1038/s41538-018-0033-5", "PMC6550218", "31304273"]}, {"Citation": "Hellinger R., Gruber C. W. (2019). Peptide-based protease inhibitors from plants. Drug Discov. Today 24 (9), 1877\u20131889. 10.1016/j.drudis.2019.05.026", "ArticleIdList": ["10.1016/j.drudis.2019.05.026", "PMC6753016", "31170506"]}, {"Citation": "Ho T., Wu S., Chen J., Li C., Hsiang C. (2007). Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antivir. Res. 74 (2), 92\u2013101. 10.1016/j.antiviral.2006.04.014", "ArticleIdList": ["10.1016/j.antiviral.2006.04.014", "PMC7114332", "16730806"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kr\u00fcger N., Herrler T., Erichsen S., et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181 (2), 271\u2013280. 10.1016/j.cell.2020.02.052", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 395 (10223), 497\u2013506. 10.1016/s0140-6736(20)30183-5", "ArticleIdList": ["10.1016/s0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., et al. (2005). Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436 (7047), 112\u2013116. 10.1038/nature03712", "ArticleIdList": ["10.1038/nature03712", "PMC7094998", "16001071"]}, {"Citation": "Joshi T., Joshi T., Sharma P., Mathpal S., Pundir H., Bhatt V., et al. (2020). In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. Eur. Rev. Med. Pharmacol. Sci. 24 (8), 4529\u20134536. 10.26355/eurrev_202004_21036", "ArticleIdList": ["10.26355/eurrev_202004_21036", "32373991"]}, {"Citation": "Kai H., Kai M. (2020). Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. Hypertens. Res. 43 (7), 648\u2013654. 10.1038/s41440-020-0455-8", "ArticleIdList": ["10.1038/s41440-020-0455-8", "PMC7184165", "32341442"]}, {"Citation": "Khan A., Benthin C., Zeno B., Albertson T. E., Boyd J., Christie J. D., et al. (2017). A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit. Care (London, England) 21 (1), 234. 10.1186/s13054-017-1823-x", "ArticleIdList": ["10.1186/s13054-017-1823-x", "PMC5588692", "28877748"]}, {"Citation": "Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., et al. (2005). A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11 (8), 875\u2013879. 10.1038/nm1267", "ArticleIdList": ["10.1038/nm1267", "PMC7095783", "16007097"]}, {"Citation": "Kumar B. K., Sekhar K. V. G. C., Kunjiappan S., Jamalis J., Bala\u00f1a-Fouce R., Tekwani B. L., et al. (2020a). Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19. Bioorg. Chem. 104,.104269. 10.1016/j.bioorg.2020.104269", "ArticleIdList": ["10.1016/j.bioorg.2020.104269", "PMC7476961", "32947136"]}, {"Citation": "Kumar S., Nyodu R., Maurya V. K., Saxena S. K. (2020b). \u201cMorphology, genome organization, replication, and pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),\u201d in Coronavirus disease 2019 (COVID-19): epidemiology, pathogenesis, diagnosis, and therapeutics. Editor Saxena S. K. (Singapore: Springer Singapore; ), 23\u201331."}, {"Citation": "Kumar V., Dhanjal J. K., Bhargava P., Kaul A., Wang J., Zhang H., et al. (2020c). Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. J. Biomol. Struct. Dyn., 1\u201313. 10.1080/07391102.2020.1775704", "ArticleIdList": ["10.1080/07391102.2020.1775704", "PMC7309304", "32469279"]}, {"Citation": "Lalaoui R., Bakour S., Raoult D., Verger P., Sokhna C., Devaux C., et al. (2020). What could explain the late emergence of COVID-19 in Africa?. New Microbes New Infect. 38, 100760. 10.1016/j.nmni.2020.100760", "ArticleIdList": ["10.1016/j.nmni.2020.100760", "PMC7508045", "32983542"]}, {"Citation": "Letko M., Marzi A., Munster V. (2020). Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 5 (4), 562\u2013569. 10.1038/s41564-020-0688-y", "ArticleIdList": ["10.1038/s41564-020-0688-y", "PMC7095430", "32094589"]}, {"Citation": "Li M. Y., Li L., Zhang Y., Wang X. S. (2020a). Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. poverty 9 (1), 45. 10.1186/s40249-020-00662-x", "ArticleIdList": ["10.1186/s40249-020-00662-x", "PMC7186534", "32345362"]}, {"Citation": "Li Y. C., Bai W. Z., Hashikawa T. (2020b). The neuroinvasive potential of SARS\u2010CoV2 may play a role in the respiratory failure of COVID\u201019 patients. J. Med. Virol. 92 (6), 552\u2013555. 10.1002/jmv.25728", "ArticleIdList": ["10.1002/jmv.25728", "PMC7228394", "32104915"]}, {"Citation": "Li Z., Wu M., Guo J., Yao J., Liao X., Song S., et al. (2020c). Caution on kidney dysfunctions of 2019-nCoV patients. MedRxiv. 10.1101/2020.02.08.20021212", "ArticleIdList": ["10.1101/2020.02.08.20021212"]}, {"Citation": "Liao W., Fan H., Davidge S. T., Wu J. (2019). Egg white-derived antihypertensive peptide IRW (Ile-Arg-Trp) reduces blood pressure in spontaneously hypertensive rats via the ACE2/ang (1-7)/mas receptor Axis . Mol. Nutr. Food Res. 63 (9), e1900063. 10.1002/mnfr.201900063", "ArticleIdList": ["10.1002/mnfr.201900063", "PMC6594022", "30913349"]}, {"Citation": "Liao W. (2019). Food protein-derived peptides targeting angiotensin converting enzyme 2. Education and research archive (ERA). Edmonton, Alberta: University of Alberta; (Accessed October 15, 2020). 10.7939/r3-4v2n-7x45", "ArticleIdList": ["10.7939/r3-4v2n-7x45"]}, {"Citation": "Lippi G., Lavie C. J., Henry B. M., Sanchis-Gomar F. (2020). Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)? Clin. Chem. Lab. Med. (Cclm), 1 10.1515/cclm-2020-0727", "ArticleIdList": ["10.1515/cclm-2020-0727", "32598305"]}, {"Citation": "Liu H., Jiang Y., Li M., Yu X., Sui D., Fu L. (2019). Ginsenoside Rg3 attenuates angiotensin II-mediated renal injury in rats and mice by upregulating angiotensin-converting enzyme 2 in the renal tissue. Evidence-Based Complement. Altern. Med. 10.1155/2019/6741057", "ArticleIdList": ["10.1155/2019/6741057", "PMC6915024", "31885658"]}, {"Citation": "Liu R., Zhang M., Wyche T. P., Winston-McPherson G. N., Bugni T. S., Tang W. (2012). Stereoselective preparation of cyclobutanes with four different substituents: total synthesis and structural revision of pipercyclobutanamide A and piperchabamide G. Angew. Chem. Int. Ed. 51 (30), 7503\u20137506. 10.1002/anie.201203379", "ArticleIdList": ["10.1002/anie.201203379", "PMC3444511", "22715150"]}, {"Citation": "Majumdar S., Mohanta B. C., Chowdhury D. R., Banik R., Dinda B., Basak A. (2010). Proprotein convertase inhibitory activities of flavonoids isolated from Oroxylum indicum. Cmc 17 (19), 2049\u20132058. 10.2174/092986710791233643", "ArticleIdList": ["10.2174/092986710791233643", "20423311"]}, {"Citation": "Majumder K., Liang G., Chen Y., Guan L., Davidge S. T., Wu J. (2015). Egg ovotransferrin\u2010derived ACE inhibitory peptide IRW increases ACE2 but decreases proinflammatory genes expression in mesenteric artery of spontaneously hypertensive rats. Mol. Nutr. Food Res. 59 (9), 1735\u20131744. 10.1002/mnfr.201500050", "ArticleIdList": ["10.1002/mnfr.201500050", "PMC5034750", "26016560"]}, {"Citation": "Malami I., Abdul A. B., Abdullah R., Bt Kassim N. K., Waziri P., Christopher Etti I. (2016). Silico discovery of potential uridine-cytidine kinase 2 inhibitors from the rhizome of alpinia mutica, Molecules (Basel, Switzerland),21, 417 10.3390/molecules21040417", "ArticleIdList": ["10.3390/molecules21040417", "PMC6274218", "27070566"]}, {"Citation": "Marian A. J. (2013). The discovery of the ACE2 gene. Circ. Res. 112 (10), 1307\u20131309. 10.1161/circresaha.113.301271", "ArticleIdList": ["10.1161/circresaha.113.301271", "23661710"]}, {"Citation": "Monteil V., Kwon H., Prado P., Hagelkr\u00fcys A., Wimmer R. A., Stahl M., et al. (2020). Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181 (4), 905\u2013913. 10.1016/j.cell.2020.04.004", "ArticleIdList": ["10.1016/j.cell.2020.04.004", "PMC7181998", "32333836"]}, {"Citation": "Moyo M., Aremu A. O., Van Staden J. (2015). Medicinal plants: an invaluable, dwindling resource in sub-Saharan Africa. J. Ethnopharmacology 174, 595\u2013606. 10.1016/j.jep.2015.04.034", "ArticleIdList": ["10.1016/j.jep.2015.04.034", "25929451"]}, {"Citation": "Muhammad A., Mada S. B., Malami. I., Forcados G. E., Erukainure O. L., Sani H. (2018). Postmenopausal osteoporosis and breast cancer: the biochemical links and beneficial effects of functional foods. Biomed. Pharmacother. = Biomedecine pharmacotherapie 107, 571\u2013582 .10.1016/j.biopha.2018.08.018", "ArticleIdList": ["10.1016/j.biopha.2018.08.018", "30114641"]}, {"Citation": "My T. T. A., Loan H. T. P., Hai N. T. T., Hieu L. T., Hoa T. T., Thuy B. T. P., et al. (2020). Evaluation of the inhibitory activities of COVID\u201019 of Melaleuca cajuputi oil using docking simulation. ChemistrySelect 5 (21), 6312\u20136320. 10.1002/slct.202000822", "ArticleIdList": ["10.1002/slct.202000822", "PMC7300966", "32572383"]}, {"Citation": "Naqvi A. A. T., Fatima K., Mohammad T., Fatima U., Singh I. K., Singh A., et al. (2020). Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach. Biochim. Biophys. Acta (Bba) - Mol. Basis Dis. 1866 (10), 165878. 10.1016/j.bbadis.2020.165878", "ArticleIdList": ["10.1016/j.bbadis.2020.165878", "PMC7293463", "32544429"]}, {"Citation": "Ngwa W., Kumar R., Thompson D., Lyerly W., Moore R., Reid T.-E., et al. (2020). Potential of flavonoid-inspired phytomedicines against COVID-19. Molecules 25 (11), 2707. 10.3390/molecules25112707", "ArticleIdList": ["10.3390/molecules25112707", "PMC7321405", "32545268"]}, {"Citation": "Nicoletti M. (2012). Nutraceuticals and botanicals: overview and perspectives. Int. J. Food Sci. Nutr. 63 (Suppl. 1 2)\u20136. 10.3109/09637486.2011.628012", "ArticleIdList": ["10.3109/09637486.2011.628012", "22360273"]}, {"Citation": "Nittari G., Pallotta G., Amenta F., Tayebati S. K. (2020). Current pharmacological treatments for SARS-CoV-2: a narrative review. Eur. J. Pharmacol. 882, 173328. 10.1016/j.ejphar.2020.173328", "ArticleIdList": ["10.1016/j.ejphar.2020.173328", "PMC7320862", "32603692"]}, {"Citation": "Ohashi H., Watashi K., Saso W., Shionoya K., Iwanami S., Hirokawa T., et al. (2020). Multidrug treatment with nelfinavir and cepharanthine against COVID-19. bioRxiv 10.1101/2020.04.14.039925", "ArticleIdList": ["10.1101/2020.04.14.039925"]}, {"Citation": "\nOkasha K. M. (2020). Hesperidin and diosmin for treatment of COVID-19. Available from:\u2009https://clinicaltrials.gov/show/NCT04452799 (Accessed October 28, 2020). ", "ArticleIdList": ["PMC7274964", "32531538"]}, {"Citation": "Omar S., Bouziane I., Bouslama Z., Djemel A. (2020). (ACE2) from natural products: quercetin, hispidulin, and cirsimaritin exhibited better potential inhibition than hydroxy-chloroquine against COVID-19 main protease active site and ACE2. Chemrxiv. Preprint.In-silico identification of potent inhibitors of COVID-19 main protease (Mpro) and angiotensin converting enzyme 2 10.26434/chemrxiv.12181404.v1", "ArticleIdList": ["10.26434/chemrxiv.12181404.v1"]}, {"Citation": "Omotuyi I. O., Nash O., Ajiboye B. O., Olumekun V. O., Oyinloye B. E., Osuntokun O. T., et al. (2020). Aframomum melegueta K.Schum. secondary metabolites exhibit polypharmacology against SARS-CoV-2 drug targets: in vitro validation of furin inhibition.Phytotherapy research : ptr 10.1002/ptr.6843", "ArticleIdList": ["10.1002/ptr.6843", "32964551"]}, {"Citation": "Oyebode O., Kandala N.-B., Chilton P. J., Lilford R. J. (2016). Use of traditional medicine in middle-income countries: a WHO-SAGE study. Health Policy Plan. 31 (8), 984\u2013991. 10.1093/heapol/czw022", "ArticleIdList": ["10.1093/heapol/czw022", "PMC5013777", "27033366"]}, {"Citation": "Palau V., Riera M., Soler M. J. (2020). ADAM17 inhibition may exert a protective effect on COVID-19. Nephrol. Dial. Transpl. 35 (6), 1071\u20131072. 10.1093/ndt/gfaa093", "ArticleIdList": ["10.1093/ndt/gfaa093", "PMC7184459", "32291449"]}, {"Citation": "Paraiso I. L., Revel J. S., Stevens J. F. (2020). Potential use of polyphenols in the battle against COVID-19. Curr. Opin. Food Sci. 32, 149. 10.1016/j.cofs.2020.08.004", "ArticleIdList": ["10.1016/j.cofs.2020.08.004", "PMC7480644", "32923374"]}, {"Citation": "Peiris J. S. M., Yuen K. Y., Osterhaus A. D. M. E., St\u00f6hr K. (2003). The severe acute respiratory syndrome. N. Engl. J. Med. 349 (25), 2431\u20132441. 10.1056/nejmra032498", "ArticleIdList": ["10.1056/nejmra032498", "14681510"]}, {"Citation": "Poochi S. P., Easwaran M., Balasubramanian B., Anbuselvam M., Meyyazhagan A., Park S., et al. (2020). Employing bioactive compounds derived from Ipomoea obscura (L.) to evaluate potential inhibitor for SARS-CoV-2 main protease and ACE2 protein. Food Front. 10.1002/fft2.29", "ArticleIdList": ["10.1002/fft2.29", "PMC7361879", "32838301"]}, {"Citation": "Rakib A., Paul A., Chy M. N. U., Sami S. A., Baral S. K., Majumder M., et al. (2020). Biochemical and computational approach of selected phytocompounds from Tinospora crispa in the management of COVID-19. Molecules 25 (17), 3936. 10.3390/molecules25173936", "ArticleIdList": ["10.3390/molecules25173936", "PMC7504753", "32872217"]}, {"Citation": "Rattanapisit K., Shanmugaraj B., Manopwisedjaroen S., Purwono P. B., Siriwattananon K., Khorattanakulchai N., et al. (2020). Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana. Sci. Rep. 10 (1), 17698. 10.1038/s41598-020-74904-1", "ArticleIdList": ["10.1038/s41598-020-74904-1", "PMC7573609", "33077899"]}, {"Citation": "Ren X., Shao X.-X., Li X.-X., Jia X.-H., Song T., Zhou W.-Y., et al. (2020). Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach. J. Ethnopharmacology 258, 112932. 10.1016/j.jep.2020.112932", "ArticleIdList": ["10.1016/j.jep.2020.112932", "PMC7196535", "32376368"]}, {"Citation": "Sakshi C., Harikrishnan A., Jayaraman S., Choudhury A. R., Veena V. (2021). Predictive medicinal metabolites from Momordica dioica against comorbidity related proteins of SARS-CoV-2 infections. J. Biomol. Struct. Dyn., 1\u201314. 10.1080/07391102.2020.1868340", "ArticleIdList": ["10.1080/07391102.2020.1868340", "PMC7814569", "33427588"]}, {"Citation": "Senthil Kumar K. J., Gokila Vani M., Wang C. S., Chen C. C., Chen Y. C., Lu L. P., et al. (2020). Geranium and lemon essential oils and their active compounds downregulate angiotensin-converting enzyme 2 (ACE2), a SARS-CoV-2 spike receptor-binding domain, Plants (Basel, Switzerland) Epithelial cells, 9 10.3390/plants9060770", "ArticleIdList": ["10.3390/plants9060770", "PMC7355681", "32575476"]}, {"Citation": "Shah V. K., Firmal P., Alam A., Ganguly D., Chattopadhyay S. (2020). Overview of immune response during SARS-CoV-2 infection: lessons from the past. Front. Immunol. 11. 10.3389/fimmu.2020.01949", "ArticleIdList": ["10.3389/fimmu.2020.01949", "PMC7426442", "32849654"]}, {"Citation": "Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., et al. (2020). Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. USA 117 (21), 11727\u201311734. 10.1073/pnas.2003138117", "ArticleIdList": ["10.1073/pnas.2003138117", "PMC7260975", "32376634"]}, {"Citation": "Shi X., Gong E., Gao D., Zhang B., Zheng J., Gao Z., et al. (2005). Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases. Am. J. Gastroenterol. 100 (1), 169\u2013176. 10.1111/j.1572-0241.2005.40377.x", "ArticleIdList": ["10.1111/j.1572-0241.2005.40377.x", "15654797"]}, {"Citation": "Shi Y., Zhang B., Chen X.-J., Xu D.-Q., Wang Y.-X., Dong H.-Y., et al. (2013). Osthole protects lipopolysaccharide-induced acute lung injury in mice by preventing down-regulation of angiotensin-converting enzyme 2. Eur. J. Pharm. Sci. 48 (4-5), 819\u2013824. 10.1016/j.ejps.2012.12.031", "ArticleIdList": ["10.1016/j.ejps.2012.12.031", "23321685"]}, {"Citation": "Shil P. K., Kwon K.-C., Zhu P., Verma A., Daniell H., Li Q. (2014). Oral delivery of ACE2/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis. Mol. Ther. 22 (12), 2069\u20132082. 10.1038/mt.2014.179", "ArticleIdList": ["10.1038/mt.2014.179", "PMC4429699", "25228068"]}, {"Citation": "Sinha S. K., Prasad S. K., Islam M. A., Gurav S. S., Patil R. B., AlFaris N. A., et al. (2020a). Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study. J. Biomol. Struct. Dyn., 1\u201315. 10.1080/07391102.2020.1779132", "ArticleIdList": ["10.1080/07391102.2020.1779132", "PMC7309308", "32552462"]}, {"Citation": "Sinha S. K., Shakya A., Prasad S. K., Singh S., Gurav N. S., Prasad R. S., et al. (2020b). An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. J. Biomol. Struct. Dyn., 1\u201312. 10.1080/07391102.2020.1762741", "ArticleIdList": ["10.1080/07391102.2020.1762741", "PMC7232888", "32345124"]}, {"Citation": "Sui H., Yu Q., Zhi Y., Geng G., Liu H., Xu H. (2010). [Effects of apigenin on the expression of angiotensin-converting enzyme 2 in kidney in spontaneously hypertensive rats]. Wei Sheng Yan Jiu 39 (6), 693\u2013700.", "ArticleIdList": ["21351633"]}, {"Citation": "Sun T., Guan J. (2020). Novel coronavirus and the central nervous system. Eur. J. Neurol. 10.1111/ene.14227", "ArticleIdList": ["10.1111/ene.14227", "32216009"]}, {"Citation": "Takahashi S., Yoshiya T., Yoshizawa-Kumagaye K., Sugiyama T. (2015). Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean. Biomed. Res. 36 (3), 219\u2013224. 10.2220/biomedres.36.219", "ArticleIdList": ["10.2220/biomedres.36.219", "26106051"]}, {"Citation": "Tan T. K., Rijal P., Rahikainen R., Keeble A. H., Schimanski L., Hussain S., et al. (2021). A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses. Nat. Commun. 12 (1), 542. 10.1038/s41467-020-20654-7", "ArticleIdList": ["10.1038/s41467-020-20654-7", "PMC7822889", "33483491"]}, {"Citation": "Thuy B. T. P., My T. T. A., Hai N. T. T., Hieu L. T., Hoa T. T., Thi Phuong Loan H., et al. (2020). Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil. ACS omega 5 (14), 8312\u20138320. 10.1021/acsomega.0c00772", "ArticleIdList": ["10.1021/acsomega.0c00772", "PMC7123907", "32363255"]}, {"Citation": "Tikellis C., Thomas M. C. (2012). Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int. J. Pept. 2012, 256294. 10.1155/2012/256294", "ArticleIdList": ["10.1155/2012/256294", "PMC3321295", "22536270"]}, {"Citation": "To K., Tong J. H., Chan P. K., Au F. W., Chim S. S., Allen Chan K., et al. (2004). Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. J. Pathol. 202 (2), 157\u2013163. 10.1002/path.1510", "ArticleIdList": ["10.1002/path.1510", "PMC7167900", "14743497"]}, {"Citation": "Turner A. J., Tipnis S. R., Guy J. L., Rice G. I., Hooper N. M. (2002). ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors. Can. J. Physiol. Pharmacol. 80 (4), 346\u2013353. 10.1139/y02-021", "ArticleIdList": ["10.1139/y02-021", "12025971"]}, {"Citation": "Tutunchi H., Naeini F., Ostadrahimi A., Hosseinzadeh\u2010Attar M. J. (2020). Naringenin, a flavanone with antiviral and anti\u2010inflammatory effects: a promising treatment strategy against COVID \u201019. Phytotherapy Res. 34, 3137. 10.1002/ptr.6781", "ArticleIdList": ["10.1002/ptr.6781", "PMC7361426", "32613637"]}, {"Citation": "Ulu A., Harris T. R., Morisseau C., Miyabe C., Inoue H., Schuster G., et al. (2013). Anti-inflammatory effects of \u03c9-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension. J. Cardiovasc. Pharmacol. 62 (3), 285\u2013297. 10.1097/fjc.0b013e318298e460", "ArticleIdList": ["10.1097/fjc.0b013e318298e460", "PMC3773051", "23676336"]}, {"Citation": "Utomo R. Y., Ikawati M., Meiyanto E. (2020). Revealing the potency of citrus and galangal constituents to halt SARS-CoV-2 infection. Preprints, 2020030214. 10.20944/preprints202003.0214.v1", "ArticleIdList": ["10.20944/preprints202003.0214.v1"]}, {"Citation": "Verdecchia P., Cavallini C., Spanevello A., Angeli F. (2020). The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur. J. Intern. Med. 76, 14\u201320. 10.1016/j.ejim.2020.04.037", "ArticleIdList": ["10.1016/j.ejim.2020.04.037", "PMC7167588", "32336612"]}, {"Citation": "Wahedi H. M., Ahmad S., Abbasi S. W. (2020). Stilbene-based natural compounds as promising drug candidates against COVID-19. J. Biomol. Struct. Dyn. 1-10 10.1080/07391102.2020.1762743", "ArticleIdList": ["10.1080/07391102.2020.1762743", "32345140"]}, {"Citation": "Wang J., Zhao S., Liu M., Zhao Z., Xu Y., Wang P., et al. (2020a). ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism. medRxiv. 10.1101/2020.02.05.20020545", "ArticleIdList": ["10.1101/2020.02.05.20020545"]}, {"Citation": "Wang Q., Qiu Y., Li J.-Y., Zhou Z.-J., Liao C.-H., Ge X.-Y. (2020b). A unique protease cleavage site predicted in the spike protein of the novel pneumonia coronavirus (2019-nCoV) potentially related to viral transmissibility. Virol. Sin. 35 (3), 337\u2013339. 10.1007/s12250-020-00212-7", "ArticleIdList": ["10.1007/s12250-020-00212-7", "PMC7091172", "32198713"]}, {"Citation": "Wang S., Qiu Z., Hou Y., Deng X., Xu W., Zheng T., et al. (2021). AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cel Res. 10.1038/s41422-020-00460-y", "ArticleIdList": ["10.1038/s41422-020-00460-y", "PMC7791157", "33420426"]}, {"Citation": "Wang Z., Wang S., Zhao J., Yu C., Hu Y., Tu Y., et al. (2019). Naringenin ameliorates renovascular hypertensive renal damage by normalizing the balance of renin-angiotensin system components in rats. Int. J. Med. Sci. 16 (5), 644\u2013653. 10.7150/ijms.31075", "ArticleIdList": ["10.7150/ijms.31075", "PMC6566737", "31217731"]}, {"Citation": "Watanabe Y., Allen J. D., Wrapp D., McLellan J. S., Crispin M. (2020). Site-specific glycan analysis of the SARS-CoV-2 spike. Science (New York, N.Y.) 369 (6501), 330\u2013333 .10.1126/science.abb9983", "ArticleIdList": ["10.1126/science.abb9983", "PMC7199903", "32366695"]}, {"Citation": "Wei X., Zhu X., Hu N., Zhang X., Sun T., Xu J., et al. (2015). Baicalin attenuates angiotensin II-induced endothelial dysfunction. Biochem. Biophysical Res. Commun. 465 (1), 101\u2013107. 10.1016/j.bbrc.2015.07.138", "ArticleIdList": ["10.1016/j.bbrc.2015.07.138", "26239661"]}, {"Citation": "\nWHO (2004). Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 (Based on data as of the 31 December 2003)\nWorld Health Organisation (WHO). Available from:\u2009https://www.who.int/csr/sars/country/table2004_04_21/en/ (Accessed September 30, 2020). "}, {"Citation": "\nWHO (2019). WHO global report on traditional and complimentary medicine 2019. Geneva: World Health Organization; \nAvailable from:\u2009https://apps.who.int/iris/handle/10665/312342 (Accessed.September 30, 2020)."}, {"Citation": "Williamson G., Kerimi A. (2020). Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. Biochem. Pharmacol. 178, 114123. 10.1016/j.bcp.2020.114123", "ArticleIdList": ["10.1016/j.bcp.2020.114123", "PMC7316054", "32593613"]}, {"Citation": "Wu Y., Xu X., Chen Z., Duan J., Hashimoto K., Yang L., et al. (2020). Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 87, 18\u201322. 10.1016/j.bbi.2020.03.031", "ArticleIdList": ["10.1016/j.bbi.2020.03.031", "PMC7146689", "32240762"]}, {"Citation": "Yahalom-Ronen Y., Tamir H., Melamed S., Politi B., Shifman O., Achdout H., et al. (2020). A single dose of recombinant VSV-\u2206G-spike vaccine provides protection against SARS-CoV-2 challenge. Nat. Commun. 11 (1), 6402. 10.1038/s41467-020-20228-7", "ArticleIdList": ["10.1038/s41467-020-20228-7", "PMC7745033", "33328475"]}, {"Citation": "Yang L., Li Y.-T., Miao J., Wang L., Fu H., Li Q., et al. (2020a). Network pharmacology studies on the effect of Chai-Ling decoction in coronavirus disease 2019. Traditional Med. Res. 5 (3), 145\u2013159."}, {"Citation": "Yang X., Yu Y., Xu J., Shu H., Xia J. a., Liu H., et al. (2020b). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 8 (5), 475\u2013481. 10.1016/s2213-2600(20)30079-5", "ArticleIdList": ["10.1016/s2213-2600(20)30079-5", "PMC7102538", "32105632"]}, {"Citation": "Yu L., Yuan K., Phuong H. T. A., Park B. M., Kim S. H. (2016). Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor. Peptides 86, 33\u201341. 10.1016/j.peptides.2016.09.009", "ArticleIdList": ["10.1016/j.peptides.2016.09.009", "27660028"]}, {"Citation": "Zhang H., Penninger J. M., Li Y., Zhong N., Slutsky A. S. (2020a). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 46 (4), 586\u2013590. 10.1007/s00134-020-05985-9", "ArticleIdList": ["10.1007/s00134-020-05985-9", "PMC7079879", "32125455"]}, {"Citation": "Zhang Y., Geng X., Tan Y., Li Q., Xu C., Xu J., et al. (2020b). New understanding of the damage of SARS-CoV-2 infection outside the respiratory system. Biomed. Pharmacother. 127, 110195. 10.1016/j.biopha.2020.110195", "ArticleIdList": ["10.1016/j.biopha.2020.110195", "PMC7186209", "32361161"]}, {"Citation": "Zhao Y., Zhao Z., Wang Y., Zhou Y., Ma Y., Zuo W. (2020). Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. bioRxiv .10.1101/2020.01.26.919985", "ArticleIdList": ["10.1101/2020.01.26.919985", "PMC7462411", "32663409"]}, {"Citation": "Zheng J., Wang J., Pan H., Wu H., Ren D., Lu J. (2017). Effects of IQP, VEP and Spirulina platensis hydrolysates on the local kidney renin angiotensin system in spontaneously hypertensive rats. Mol. Med. Rep. 16 (6), 8485\u20138492. 10.3892/mmr.2017.7602", "ArticleIdList": ["10.3892/mmr.2017.7602", "28944898"]}, {"Citation": "Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579 (7798), 270\u2013273. 10.1038/s41586-020-2012-7", "ArticleIdList": ["10.1038/s41586-020-2012-7", "PMC7095418", "32015507"]}, {"Citation": "Zi C.-T., Zhang N., Yang L., Wang L.-X., Wu Y.-L., Su Y.-S., et al. (2020). Discovery of a potent angiotensin converting enzyme 2 inhibitor from Chinese medicinal and edible plant via docking-based virtual screening. Research square. 10.21203/rs.3.rs-32515/v1", "ArticleIdList": ["10.21203/rs.3.rs-32515/v1"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "11", "Day": "16"}, {"Year": "2021", "Month": "3", "Day": "8"}, {"Year": "2021", "Month": "5", "Day": "20", "Hour": "6", "Minute": "40"}, {"Year": "2021", "Month": "5", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "21", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "5", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["34012391", "PMC8126690", "10.3389/fphar.2021.629935", "629935"]}}], "PubmedBookArticle": []}